Aoxing Pharmaceutical Company Inc (AOXG)
OTHER OTC:AOXG
US Market
Holding AOXG?
Track your performance easily

Aoxing Pharmaceutical Company (AOXG) Financial Statements

34 Followers

Aoxing Pharmaceutical Company Financial Overview

Aoxing Pharmaceutical Company's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is ―; Aoxing Pharmaceutical Company is scheduled to report earnings on May 15, 2017, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 17Dec 16Sep 16Jun 16Mar 16
Income Statement-
Total Revenue$ 5.70M$ 8.01M$ 7.57M$ 8.82M$ 6.56M
Gross Profit$ 4.42M$ 6.30M$ 6.05M$ 6.16M$ 4.93M
EBIT$ 878.40K$ 250.54K$ 1.70M$ -1.85M$ 1.53M
EBITDA$ 1.12M$ 502.70K$ 1.95M$ -1.60M$ 1.78M
Net Income Common Stockholders$ 132.14K$ -43.45K$ 346.08K$ -1.90M$ 622.72K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.08M$ 6.85M$ 7.06M$ 6.91M$ 6.05M
Total Assets$ 62.47M$ 58.72M$ 58.77M$ 56.23M$ 58.93M
Total Debt$ 27.72M$ 24.39M$ 25.39M$ 25.47M$ 26.58M
Net Debt$ 20.64M$ 17.54M$ 18.34M$ 18.56M$ 20.53M
Total Liabilities$ 44.38M$ 40.92M$ 40.26M$ 38.16M$ 38.38M
Stockholders Equity$ 19.11M$ 18.84M$ 19.53M$ 19.14M$ 21.52M
Cash Flow-
Free Cash Flow$ -3.02M$ 81.29K$ 132.81K$ 1.41M$ -1.26M
Operating Cash Flow$ -3.02M$ 87.94K$ 134.94K$ 1.43M$ -1.25M
Investing Cash Flow$ -80.00$ -6.64K$ -2.13K$ -21.41K$ -5.94K
Financing Cash Flow$ 3.18M$ 0.00$ 0.00$ -320.98K$ 402.94K
Currency in USD

Aoxing Pharmaceutical Company Earnings and Revenue History

Aoxing Pharmaceutical Company Debt to Assets

Aoxing Pharmaceutical Company Cash Flow

Aoxing Pharmaceutical Company Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis